References
- Steen V. D., Medsger T. A. Changes in causes of death in systemic sclerosis, 1972–2002. Ann Rheum Dis 2007; 66: 940–4
- Abu‐Shakra M., Guillemin F., Lee P. Cancer in systemic sclerosis. Arthritis Rheum 1993; 36: 460–4
- Derk C. T., Rasheed M., Artlett C. M., Jimenez S. A. A cohort study of cancer incidence in systemic sclerosis. J Rheumatol 2006; 33: 1113–16
- Rosenthal A. K., McLaughlin J. K., Gridley G., Nyrén O. Incidence of cancer among patients with systemic sclerosis. Cancer 1995; 76: 910–14
- Higuchi M., Horiuchi T., Ishibashi N., Yoshizawa S., Niho Y., Nagasawa K. Anticentromere antibody as a risk factor for cancer in patients with systemic sclerosis. Clin Rheumatol 2000; 19: 123–6
- Hill C. L., Nguyen A. M., Roder D., Roberts‐Thomson P. Risk of cancer in patients with scleroderma: a population‐based cohort study. Ann Rheum Dis 2003; 62: 728–31
- Duncan S. C., Winkelmann R. K. Cancer and scleroderma. Arch Dermatol 1979; 115: 950–5
- Chatterjee S., Dombi G. W., Severson R. K., Mayes M. D. Risk of malignancy in scleroderma: a population‐based cohort study. Arthritis Rheum 2005; 52: 2415–24
- Cancer incidence in Korea 1999–2001. Ministry of Health and Welfare, Republic of Korea 2005
- LeRoy E. C., Black C., Fleischmajer R., Jablonska S., Krieg T., Medsger T. A., Jr, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988; 15: 202–5
- Hesselstrand R., Scheja A., Akesson A. Mortality and causes of death in a Swedish series of systemic sclerosis patients. Ann Rheum Dis 1998; 57: 682–6
- Czirják L., Kumánovics G., Varjú C., Nagy Z., Pákozdi A., Szekanecz Z., et al. Survival and causes of death in 366 Hungarian patients with systemic sclerosis. Ann Rheum Dis 2008; 67: 59–63
- Yang Y., Fujita J., Tokuda M., Bandoh S., Ishida T. Lung cancer associated with several connective tissue diseases: with a review of literature. Rheumatol Int 2001; 21: 106–11
- Bernatsky S., Ramsey‐Goldman R., Clarke A. Malignancy and autoimmunity. Curr Opin Rheumatol 2006; 18: 129–34
- Artinian V., Kvale P. A. Cancer and interstitial lung disease. Curr Opin Pulm Med 2004; 10: 425–34
- Bouros D., Hatzakis K., Labrakis H., Zeibecoglou K. Association of malignancy with diseases causing interstitial pulmonary changes. Chest 2002; 121: 1278–89
- Kanaji N., Fujita J., Bandoh S., Fukumoto T., Ishikawa M., Haba R., et al. Small cell lung cancer associated with systemic sclerosis. Intern Med 2005; 44: 315–18
- Peters‐Golden M., Wise R. A., Hochberg M., Stevens M. B., Wigley F. M. Incidence of lung cancer in systemic sclerosis. J Rheumatol 1985; 12: 1136–9
- Pontifex E. K., Hill C. L., Roberts‐Thomson P. Risk factors for lung cancer in patients with scleroderma: a nested case–control study. Ann Rheum Dis 2007; 66: 551–3
- Katzka D. A., Reynolds J. C., Saul S. H., Plotkin A., Lang C. A., Ouyang A., et al. Barrett's metaplasia and adenocarcinoma of the esophagus in scleroderma. Am J Med 1987; 82: 46–52
- Rothfield N., Kurtzman S., Vazques‐Abad D., Charron C., Daniels L., Greenberg B. Association of anti‐topoisomerase I with cancer. Arthritis Rheum 1992; 35: 724